Vor Biopharma signs exclusive license pact with NCI for clinical-stage CD33 CAR-T
It is currently being evaluated in a multi-site Phase 1/2 clinical trial in children and young adults with relapsed or refractory…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.